Lymphangioleiomyomatosis (LAM) is a rare lung disease that has become more treatable thanks to dedicated efforts from researchers and patient advocacy groups. ATS Past President Gregory Downey, MD, ATSF, National Jewish Health, discusses advances in understanding and treating LAM with host Ugo Ezema, MD. What role do patient networks play and what does the future hold for research?